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In vitro studies have shown that the translational inhibitory activity of 2-5 A can be blocked by the oligori- 
bonucleotide 2’,5’-(PA),. We have examined the effect of simultaneous introduction of inhibitor and antago- 
nist into intact mouse cells using calcium phosphate coprecipitation. Upon introduction of 10e4 M 2’,5’- 
(PA), and 1Om6 M 2-5 A, inhibition of protein synthesis was prevented. Efficiency of calcium phosphate 
precipitation of 2-5 A in the presence or absence of 2’,5’-(PA), was comparable. Introduction of 2’,5’-(PA), 
analogs showed that nucleotides which do not bind well to the 2-5 A dependent endonuclease do not 
prevent 2-5 A inhibitory activity. Thus, 2’,5’-(pA), functions as an antagonist of 2-5 A in vivo. 
Interferon 2-5 A 
1. INTRODUCTION 
Two interferon-induced enzymatic pathways 
leading to inhibition of translation have been iden- 
tified [1,2]. First, the protein kinase pathway in- 
volves phosphorylation of the small subunit of 
eukaryotic initiation factor, eIF-2, resulting in in- 
hibition of protein synthesis initiation. Second, the 
2-5 A pathway involves induction of a 2-5 A syn- 
thetase which, in the presence of ATP and dduble- 
stranded RNA, synthesizes 2-5 A, an activator of 
a latent endonuclease which degrades mRNA. The 
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Protein synthesis 
role of these pathways in the antiviral effect of in- 
terferon is unclear and may depend on characteris- 
tics of specific virus-cell interaction [3-g]. 
To evaluate the roles of the protein kinase and 
2-5 A pathways, we have developed a method by 
which the 2 enzyme systems might be functionally 
distinguished by specific antagonism of the 2-5 A 
pathway using a synthetic oligoribonucleotide. It 
has been previously shown that inhibition of pro- 
tein synthesis by exogenously added 2-5 A could 
be prevented by the oligoribonucleotide, 2’ ,5 ‘- 
(pA)3, in in vitro studies in mouse L cell-free 
systems [lO,ll]. In the present experiments, oligo- 
nucleotides have been introduced into intact mouse 
L cells using a modification of the calcium phos- 
phate coprecipitation technique of Graham and 
Van der Eb [12]. Under these conditions, we have 
found that 2’,5’-(pA)3 when introduced into cells, 
is able to stimulate protein synthesis and, when in- 
troduced together with 2-5 A, is able to prevent he 
protein synthesis inhibiting action of 2-5 A. 
Recently, Watling et al. [13] reported the use of an 
analog of 2-5 A to accomplish this purpose and to 
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prevent the anti-encephalomyocarditis virus action 
of interferon. 
2. MATERIALS AND METHODS 
Mouse L cells were maintained in Dulbecco’s 
modified Eagles minimum essential medium 
(MEM) containing 10% heat-inactivated fetal calf 
serum. 
The calcium phosphate coprecipitation tech- 
nique used for transfection was a modification of 
the method of Panet et al. [14]. To assess the 
number of cells present following the transfection, 
cells were washed with leucine-free MEM and in- 
cubated at 37’C in leucine-free MEM containing 
10 &i/ml L-[4,5-3H(n)]leucine. After 1 h, the 
medium was aspirated and the procedure in [14] 
followed. 
The o!igonucleotides employed in this study 
were prepared either as described in [ 15,161 for 2-5 
A trimer and 2’ ,5 ’ -(pA)3 or were obtained from 
commercial sources: poly(A) and 3 ’ ,5 ’ -(p2’ dA)3 
from P.-L. Biochemicals (Milwaukee, WI) and 
5 ‘-AMP from Aldrich (Milwaukee, WI). The 
[3H]2-5 A was prepared from [3H]ATP (Amer- 
sham-Searle, Chicago, IL; final spec. act. 45 x lo6 
cpm/pmol) by incubation with 2-5 A synthetase 
from interferon-treated mouse L cells adsorbed to 
poly(I)-poly(C)-Sepharose, according to [ 17). The 
2-5 A trimer 5 ’ -triphosphate was purified by high- 
performance liquid chromatography on a Bon- 
dapack column with a O-20% gradient of am- 
monium phosphate (50 PM, pH 7) into methanol/ 
water (1: 1). The product had a final specific 
activity of 1.4 X lo6 cpm/_&o unit. 
3. RESULTS 
The results from a single transfection experi- 
ment in which 2-5 A and 2’ ,5 ‘-(pA)3 were in- 
troduced simultaneously into intact cells are 
presented in fig. 1. The extent to which protein syn- 
thesis was inhibited by 2-5 A was dependent upon 
the concentration of the oligonucleotide. At 10e9 
M, 2-5 A did not have any effect on protein syn- 
thesis. However, as the concentration of 2-5 A ap- 
proached 10m6 M, the level of protein synthesis 
dropped to less than 30% of the control. In con- 
trast, protein synthesis in cells exposed to precipi- 
tates containing only 2’ ,5 ‘-(pA)3 was significantly 
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Fig. 1. Effect of 2 ’ ,5 ’ -(pA)3 on inhibition of protein syn- 
thesis by 2-5 A. Mouse L cells, labeled prior to transfec- 
tion with 10 ,&i/ml [3H]leucine, were exposed to vary- 
ing concentrations of calcium phosphate-precipitated 
2’,5’-(pA)3 (m), 2-5 A (A), 10e4 M 2’,5’-(pA)3 and 2-5 
A at the indicated concentrations (0), 10m5 M 2',5'- 
(PA), and 2-5 A at the indicated concentrations (0). 
Each determination represents an average of 4 replicate 
samples. The level of 100% protein synthesis is defined 
as cpm [3SS]Met/cpm [3H]Leu as determined in mock- 
transfected cells. 
enhanced and this stimulation was dose-dependent. 
When 2-5 A and 2’ ,5 ’ -(pA)3 were simultaneous- 
ly introduced into L cells, inhibition of protein 
synthesis by 2-5 A was effectively reduced and this 
reduction was dependent upon the concentration 
of 2’ ,5 ‘-(PA),. For example, introduction of 10d6 
M 2-5 A into the cells resulted in a reduction in the 
level of protein synthesis to 29%. When 2’ ,5 ’ - 
(pA)3 was present at 10 -5 M, the level of protein 
synthesis was reduced by 2-5 A to only 40%. Fur- 
thermore, when 2’,5’-(pA)3 was present at low4 
M, the level af protein synthesis was only slightly 
reduced to 72%. A similar antagonistic effect of 
2’,5’-(pA)3 on inhibition of protein synthesis by 
2-5 A at lo-’ and lo-* M was also observed. 
However, only when less effective concentrations 
of 2-5 A (lo-‘, lo-’ M) were introduced did 
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2’ ,5 ‘-(pA)3 overcome the inhibitory properties of 
the 2-5 A and bring levels of protein synthesis up 
to those of mock-transfected control cells. 
The specificity of antagonism was investigated 
by examining the effect of several 2’ ,5 ’ -(pA)3 
related adenosine-containing nucleotides, each 
simultaneously transfected with 2-5 A. The selected 
compounds had been evaluated previously in an L 
cell-free protein synthesis ystem and were observed 
(i) to have no effect on inhibition of protein syn- 
thesis by 2-5 A and (ii) to lack any inhibitory pro- 
perties of their own (not shown; see [18] for 
reference). The results from several transfection 
experiments in which 2 ’ ,5 ’ -(pA)3 and various 
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adenosine nucleotides were compared for the abili- 
ty to antagonize 2-5 A-mediated inhibition of pro- 
tein synthesis are summarized in fig.2. The level of 
protein synthesis inhibition in the presence of 2-5 
A is designated as 100%; the level of protein syn- 
thesis observed in the presence or absence of other 
nucleotides is expressed as a percentage relative to 
that value. The cointroduction of 2 ’ ,5 ’ -(pA)3, at a 
concentration, based on adenosine residues (MA), 
of 3 x 10m4 MA with lo-’ M 2-5 A effectively in- 
creased the level of protein synthesis from 100 to 
136% (fig.2B). In contrast, the simultaneous in- 
troduction of 3’ ,5’-(p2’dA)~ (3 x 10m4 Mn) with 
2-5 A (lo-’ M) did not significantly affect the level 
With 2-5A (lo-’ M) Without 2-5A (lo-’ M) 
Fig.2. Effect of adenosine-containing nucleotides on inhibition of protein synthesis by 2-5 A. L cells were treated with 
calcium phosphate precipitates containing 2-5 A alone, or an adenosine nucleotide alone, or with 2-5 A and an 
adenosine nucleotide, as indicated, in 3 separate experiments. The 2-5 A was applied at a final concentration, based 
on adenosine residues (MA), of 10m6 MA (A) or lo-’ MA (B) and the adenosine nucleotide was applied at a final MA 
of 3 x 1O-4 MA (and 3 x 10m5 MA for 5’-AMP). 100% represents the level of protein synthesis inhibition in the presence 
of 2-5 A alone. The results with the other nucleotides are expressed as a percentage relative to that value. In each experi- 
ment, all compounds were evaluated in quadruplicate. The values given for 2’ ,5’-(pA)3 and 5’-AMP (3 x 10m4 MA) 
also represent he average from all 3 separate experiments. 
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of inhibited protein synthesis. With addition of 
3 ’ ,5 ’ -(p2 ’ dA)s and 10e6 M 2-5 A, the level of pro- 
tein synthesis increased slightly to 122% compared 
to 152% with addition of 2’,5’- (pA)3 and 2-5 A 
(10m6 M) (fig.2A). Furthermore, AMP, at 3 x 
10e4 or 3 x 10m5 MA, or poly(A), at a concentra- 
tion equimolar to 2 ’ ,5 ’ -(pA)3 was introduced with 
2-5 A into L cells. The levels of protein synthesis 
were not significantly affected by cotransfection of 
either of the adenosine-containing compounds 
with 2-5 A. Multiple transfections indicated that 
introduction of 2’ ,5 ’ -(pA)s, AMP, or poly(A), 
alone into mouse cells did not result in any inhibi- 
tion of protein synthesis. 
To evaluate the possibility that 2’ ,5 ‘-(pA)3 was 
acting nonspecifically to inhibit 2-5 A due to more 
efficient precipitation of 2’,5’-(pA)3 than 2-5 A 
by calcium phosphate, an experiment was designed 
in which the amount of 2-5 A precipitated in the 
presence or absence of 2’ ,5 ’ -(pA)s was compared. 
Radioactively labeled 2-5 A trimer triphosphate, 
prepared by HPLC purification of 2-5 A obtained 
from a 2-5 A synthetase reaction, was precipitated 
with or without 2’ ,5 ’ -(pA)3 and the amount of un- 
precipitated radioactivity in the supernatant of 
each pelleted sample was measured (not shown). 
Upon addition of unlabeled 2’ ,5 ’ -(pA)3 to 2-5 A, 
the amount of unprecipitated radioactivity was 
slightly reduced. Therefore, the presence of the an- 
tagonist in precipitation mixtures did not affect the 
efficiency at which the inhibitor was precipitated 
with calcium phosphate. This conclusion is further 
supported by the observation that the dose re- 
sponse to 2-5 A remained linear in the presence of 
a uniform concentration of antagonist (see fig.1). 
4. DISCUSSION 
Multiple responses are elicited in cells which 
have been exposed to interferon. As of yet, it is not 
clear what mechanisms are responsible for media- 
ting the various activities of interferon. We have 
now shown that simultaneous introduction of 2-5 
A and the corresponding 5 ’ -monophosphate, 
2’ ,5 ‘-(pA)3, into living cells results in prevention 
of the inhibition of protein synthesis by 2-5 A. The 
development of this system, in which the 2-5 A en- 
zymatic pathway induced by interferon treatment 
can be functionally antagonized in living cells, may 
provide a model with which to assess the nature of 
the participation of this 2-5 A pathway in inter- 
feron-induced cellular and viral responses. 
An additional phenomenon associated with in- 
troduction of antagonist was observed. Upon in- 
troduction of 2’ ,5 ’ -(pA)3 or its analogs alone into 
L cells, protein synthesis was significantly stimu- 
lated in a dose-dependent manner (figs 1,2A and 
B). This enhancement was consistently observed 
with 2’,5’-(pA)3, 5’-AMP, and poly(A). The abili- 
ty to antagonize 2-5 A-mediated inhibition of pro- 
tein synthesis did, not correlate with the level of 
enhancement of protein synthesis. This effect was 
not observed with the same oligonucleotides in the 
in vitro cell-free translation system (not shown). 
Evidence obtained from t3H]leucine labeling of the 
cells to measure the extent of cell loss during the 
harsh transfection procedure indicated that treat- 
ment of the cells with precipitates containing the 
oligonucleotides may somehow stabilize the cells 
since the number of cells remaining after manipu- 
lations increased slightly in the presence of precipi- 
tates containing the antagonist or its analogs. 
Alternatively, these adenosine nucleotides, which 
do not inhibit protein synthesis, may participate 
more directly at the level of protein synthesis to 
mediate this enhancement phenomenon. Further 
investigation of the involvement of 2-5 A related 
oligonucleotides in stimulating protein synthesis 
may provide information regarding the regulation 
of cellular biosynthesis. 
The evidence presented in this report that 2’ ,5 ’ - 
(pA)3 acts as an antagonist of 2-5 A inhibitory ac- 
tivity contrasts sharply with results obtained from 
similar experiments using intact mouse L cells by 
Haugh et al. [19]. Using the calcium phosphate 
precipitation technique to introduce oligonucleo- 
tides into L cells, these workers observed inhibition 
of protein synthesis by 50 ,uM 2 ’ ,5 ’ -(pA)3 2 h after 
removal of the precipitate from the cells. Further- 
more, simultaneous introduction of 50 ,uM 2’ ,5 ‘- 
(pA)3 with 50 nM 2-5 A (a lOOO-fold difference in 
concentration) did not affect the level of inhibition 
of protein synthesis by 2-5 A. In our system, the 
addition of 100 ,uM 2’ ,5 ’ -(pA)3 reproducibly 
stimulates L cell protein synthesis by 2.25 h after 
removal of the precipitate. Moreover, cointroduc- 
tion of 100 FM 2’ ,5 ’ -(pA)3 and 1 ,uM 2-5 A (a 
lOO-fold difference in concentration) results in a 
dramatic antagonism of 2-5 A inhibitory activity. 
These contrasting results may reflect differences in 
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the length of time the cells are exposed to the 
potentially toxic calcium phosphate precipitate. 
The cells of Haugh et al. [19] were treated with the 
precipitate for 2 h; whereas, during this investiga- 
tion, cells were incubated with precipitate for 45 
min and the level of protein synthesis was deter- 
mined with respect to the total number of cells pre- 
sent after manipulation. However, these con- 
flicting results cannot be totally reconciled by 
technical differences since in vitro experiments 
using L cell-free protein synthesis systems have 
also provided results that are at odds [lo, 11,19, 
201. Therefore, it would be valuable to examine the 
effectiveness of 2’,5’-(pA)s antagonism in other 
systems. Miyamoto et al. [I I], for instance, found 
that 2’,5’-(pA)3 could completely block the 2-5 A- 
dependent degradation of reovirus RNA in mouse 
fibroblasts, in agreement with our earlier results 
1101. 
In summary, 2’ ,5 ’ -(pA)3 was found to stimulate 
protein synthesis in intact cells and to prevent the 
translational inhibitory effects of 2-5 A. Whether 
there is a causal relationship between these phe- 
nomena and the 2-5 A synthetase/2-5 A-depend- 
ent endonuclease system, as it has been described 
thus far, remains to be determined. 
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